TrumpRx: Because Your Life Depends on the 'Right Kind' of Corporate Greed
Oh, the glorious spectacle of American 'innovation'! While the children of Gaza starve amidst heaps of US-funded rubble, and hospitals are bombed into oblivion because they dared to treat the 'wrong' kind of humans, the titans of industry here are busy making sure your Adderall costs slightly less if you vote the 'right' way. It’s not about curing disease, dear reader; it’s about curating
convenience for the privileged and weaponizing medicine for political theater. The New York Times, bless its heart, meticulously dissects how a TrumpRx-Pfizer handshake might shuffle the deck of your drug costs. This isn't journalism; it’s a detailed financial report on the latest episode of 'Bread and Circuses.' They'd rather you analyze the intricacies of your co-pay than question why a nation
so rich can't guarantee basic healthcare, or why it funds a genocidal regime while its own citizens grapple with medical debt. Think of it as the ultimate double standard, writ large. One rule for 'allies' in the 'War on Terror' – endless billions for ethnically cleansing populations – and another for American citizens – a coupon for your cholesterol meds, but only if it serves the
corporate-political machine. The 'democracy' they preach exists only in the pockets of pharmaceutical executives and military contractors, who apparently suffer from chronic 'profit deficiency syndrome.' Meanwhile, the global south, perpetually pillaged and starved by the same systems that manufacture both bombs and highly priced medications, watches on. They understand that 'deals' like these